Although detailed investigation is required, NECTIN4 may partly contribute to the acquisition of drug-resistance and these results imply the potency of NECTIN4 as a target of novel drugs for BRAFi-resistant melanoma. The gene discussed is NECTIN4; the disease is melanoma.